Inventor · disambiguated record
Justin Wong
Also filed as: WONG JUSTIN · WONG JUSTIN G · WONG JUSTIN G P
17 granted patents·18 pending applications·163 citations·filing 1999–2021
93Inventor score
Top patents by PatentIndex Score
35 records- 0196US8206715B2Antibodies that bind colony stimulating factor 1 receptor (CSF1R)WONG JUSTIN·Filed 2011·Granted Jun 26, 2012·46 cites·6 claims
- 0294US8747845B2Methods of treatment by administering antibodies that bind colony stimulating factor 1 receptor (CSF1R)WONG JUSTIN·Filed 2012·Granted Jun 10, 2014·25 cites·13 claims
- 0394US8580936B2Polynucleotides encoding FGFR1-IIIc ECD fusion proteinsWILLIAMS LEWIS T·Filed 2011·Granted Nov 12, 2013·40 cites·25 claims
- 0489US9957327B2Antibodies that bind colony stimulating factor 1 receptor (CSF1R)FIVE PRIME THERAPEUTICS INC·Filed 2016·Granted May 1, 2018·5 cites·24 claims
- 0589US7776564B2Stromal cell-derived factor-1 polypeptides, polynucleotides, modulators thereof and methods of useFIVE PRIME THERAPEUTICS INC·Filed 2005·Granted Aug 17, 2010·15 cites·13 claims
- 0680US2022153851A1Antibodies that Bind Colony Stimulating Factor 1 Receptor (CSF1R)FIVE PRIME THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0775US9200075B2Nucleic acids encoding antibodies that bind colony stimulating factor 1 receptor (CSF1R)FIVE PRIME THERAPEUTICS INC·Filed 2014·Granted Dec 1, 2015·1 cites·23 claims
- 0874US11186646B2Antibodies that bind colony stimulating factor 1 receptor (CSF1R)FIVE PRIME THERAPEUTICS INC·Filed 2020·Granted Nov 30, 2021·0 cites·19 claims
- 0974US10982001B2Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R)FIVE PRIME THERAPEUTICS INC·Filed 2016·Granted Apr 20, 2021·1 cites·17 claims
- 1073US2009286954A1Human cDNA Clones Comprising Polynucleotides Encoding Polypeptides and Methods of Their UseFIVE PRIME THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 1172US8575312B2Compositions and methods of use for MGD-CSF in disease treatmentBEHRENS DIRK·Filed 2012·Granted Nov 5, 2013·2 cites·11 claims
- 1271US6803194B1Use of ribozymes for functionating genesHK PHARMACEUTICALS INC·Filed 1999·Granted Oct 12, 2004·28 cites·11 claims
- 1370US2008182974A1Human cDNA clones comprising polynucleotides encoding polypeptides and methods of their useFIVE PRIME THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 1469US10562970B2Antibodies that bind colony stimulating factor 1 receptor (CSF1R)FIVE PRIME THERAPEUTICS INC·Filed 2018·Granted Feb 18, 2020·0 cites·28 claims
- 1566US9192683B2Methods of treating disease with FGFR1 fusion proteinsFIVE PRIME THERAPEUTICS INC·Filed 2013·Granted Nov 24, 2015·0 cites·21 claims
- 1666US2021277130A1Methods of Treating Conditions with Antibodies that Bind Colony Stimulating Factor 1 Receptor (CSF1R)FIVE PRIME THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1765US9173957B2FGFR2 fusion proteins comprising C-terminal deletion mutants of FGFR2-IIICFIVE PRIME THERAPEUTICS INC·Filed 2013·Granted Nov 3, 2015·0 cites·6 claims
- 1864US2017349643A1Compositions and methods of treating disease with fgfr fusion proteinsFIVE PRIME THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1963US8178109B2Compositions and methods of use for MGD-CSF in disease treatmentBEHRENS DIRK·Filed 2009·Granted May 15, 2012·0 cites·12 claims
- 2063US2006084799A1Human cDNA clones comprising polynucleotides encoding polypeptides and methods of their useWILLIAMS LEWIS T·Filed 2004·Application pending·0 cites
- 2162US9695243B2Antibodies that bind colony stimulating factor 1 receptor (CSF1R)FIVE PRIME THERAPEUTICS INC·Filed 2015·Granted Jul 4, 2017·0 cites·14 claims
- 2259US2016096876A1Compositions and methods of treating disease with fgfr fusion proteinsFIVE PRIME THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 2358US2013302322A1Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (csf1r)FIVE PRIME THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 2457US2014170145A1Compositions and methods of use for mgd-csf in disease treatmentFIVE PRIME THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 2555US2014086840A1Therapeutic Antibody Target Validation and Screening In VivoFIVE PRIME THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 2653US2010028867A1LRRTM1 Compositions and Methods of Their Use for the Diagnosis and Treatment of CancerBOSCH ELIZABETH·Filed 2006·Application pending·0 cites
- 2752US2003087288A1Use of ribozymes for functionating genesFiled 2002·Application pending·0 cites
- 2852US2007274988A1Kiaa0779, Splice Variants Thereof, and Methods of Their UseFIVE PRIME THERAPEAUTICS INC·Filed 2004·Application pending·0 cites
- 2951US2007264277A1Compositions and Methods of Use for Mgd-Csf in Disease TreatmentBEHRENS DIRK·Filed 2005·Application pending·0 cites
- 3050US2009252738A1Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ixNOVARTIS VACCINES & DIAGNOSTIC·Filed 2003·Application pending·0 cites
- 3149US8404810B2Compositions and methods of use for modulators of polypeptides and polynucleotides in treating breast cancer and melanomaHESTIR KEVIN·Filed 2007·Granted Mar 26, 2013·0 cites·6 claims
- 3247US2007248605A1Fibroblast Growth Factor Receptors 1,2,3, and 4 as Targets for Therapeutic InterventionFIVE PRIME THERAPETUTICS INC·Filed 2004·Application pending·0 cites
- 3346US8058403B2Antibodies to stromal cell-derived factor-1 polypeptidesCHU KETING·Filed 2010·Granted Nov 15, 2011·0 cites·9 claims
- 3446US2012183477A1Therapeutic Antibody Target Validation and Screening In VivoWILLIAMS LEWIS T·Filed 2010·Application pending·0 cites
- 3541US2009214517A1Compositions and methods of use for modulators of nectin 4, semaphorin 4b, igsf9, and kiaa0152 in treating diseaseWONG JUSTIN·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →